Hepatic Impairment (HI)
Gastroenterology
1
Pipeline Programs
1
Companies
1
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Clinical Trials (1)
Total enrollment: 32 patients across 1 trials
A Study to Evaluate EDG-7500 in Adults With Hepatic Impairment
Start: Jan 2026Est. completion: May 202632 patients
Phase 1Recruiting
Related Jobs in Gastroenterology
Specialty Representative, Gastroenterology – Minneapolis, Minnesota
AbbVie
Remote
12h ago
Head of Drug Product Development
Ironwood Pharmaceuticals
Boston, Massachusetts, United States
13h ago
$246K - $287K/yr
Regulatory Affairs Associate
Ferring Pharmaceuticals
Istanbul, Turkey
Yesterday
Key Account Director, Diagnostics and Research
Tempus
Remote
Yesterday
$150K - $200K/yr
Senior Sterilization Validation Engineer (m/f/d)
Johnson & Johnson
Beerse, Antwerp, Belgium
Yesterday
Senior Financial Analyst - Supply Chain Finance & Transformation (m/f/d)
Johnson & Johnson
Norderstedt, Schleswig-Holstein, Germany
Yesterday
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 32 patients
1 companies competing in this space